ClearPoint Neuro (CLPT) Income towards Parent Company (2011 - 2026)
ClearPoint Neuro (CLPT) posted Income towards Parent Company of -$9.6 million for Q1 2026, down 23.2% sequentially from -$7.8 million in Q4 2025, and down 58.51% YoY from -$23.0 million in Q1 2025.
ClearPoint Neuro (CLPT) Income towards Parent Company (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Income towards Parent Company for 15 years, with the latest figure at -$9.6 million in Q1 2026.
- Quarterly Income towards Parent Company fell 58.51% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.0 million (down 44.21% YoY) and the FY2025 annual result came in at -$25.5 million, down 39.75% from the prior year.
- Income towards Parent Company declined to -$9.6 million in Q1 2026 per CLPT's latest filing, from -$7.8 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at -$4.1 million in Q1 2024 and troughed at -$14.7 million in Q2 2022.
- A 5-year average of -$7.6 million and a median of -$6.0 million in 2025 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2024 and 2025: Income towards Parent Company jumped 62.47% in 2024, then plunged 64.12% in 2025.
- Over 5 years, Income towards Parent Company stood at -$4.6 million in 2022, then dropped by 5.47% to -$4.9 million in 2023, then advanced by 3.49% to -$4.7 million in 2024, then tumbled by 64.12% to -$7.8 million in 2025, then slipped by 23.2% to -$9.6 million in 2026.
- According to Business Quant data, Income towards Parent Company over the past three periods registered -$9.6 million, -$7.8 million, and -$5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn |
| 10 | ClearPoint Neuro | 469.09 Mn | 439.69 Mn | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.34 Mn |
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -4.72 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.05 Mn |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -14.68 Mn |
| Mar 31, 2022 | -11.36 Mn |
| Dec 31, 2021 | -4.46 Mn |
| Sep 30, 2021 | -19.13 Mn |